Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Other Non-Current Assets (2018 - 2025)

AdaptHealth has reported Other Non-Current Assets over the past 8 years, most recently at $19.1 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $19.1 million for Q4 2025, down 63.75% from a year ago — trailing twelve months through Dec 2025 was $19.1 million (down 63.75% YoY), and the annual figure for FY2025 was $19.1 million, down 63.75%.
  • Other Non-Current Assets for Q4 2025 was $19.1 million at AdaptHealth, up from $18.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for AHCO hit a ceiling of $52.7 million in Q4 2024 and a floor of $12.1 million in Q3 2021.
  • Median Other Non-Current Assets over the past 5 years was $19.4 million (2021), compared with a mean of $20.7 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 238.68% in 2021 and later tumbled 63.75% in 2025.
  • AdaptHealth's Other Non-Current Assets stood at $15.1 million in 2021, then soared by 48.46% to $22.4 million in 2022, then fell by 5.74% to $21.1 million in 2023, then surged by 149.66% to $52.7 million in 2024, then tumbled by 63.75% to $19.1 million in 2025.
  • The last three reported values for Other Non-Current Assets were $19.1 million (Q4 2025), $18.9 million (Q1 2025), and $52.7 million (Q4 2024) per Business Quant data.